ATA30383A - METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID - Google Patents

METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID

Info

Publication number
ATA30383A
ATA30383A AT0030383A AT30383A ATA30383A AT A30383 A ATA30383 A AT A30383A AT 0030383 A AT0030383 A AT 0030383A AT 30383 A AT30383 A AT 30383A AT A30383 A ATA30383 A AT A30383A
Authority
AT
Austria
Prior art keywords
cyclic
producing
pharmaceutical composition
nasal administration
ergot peptide
Prior art date
Application number
AT0030383A
Other languages
German (de)
Other versions
AT385656B (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA30383A publication Critical patent/ATA30383A/en
Application granted granted Critical
Publication of AT385656B publication Critical patent/AT385656B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0030383A 1982-02-01 1983-01-31 METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID AT385656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (2)

Publication Number Publication Date
ATA30383A true ATA30383A (en) 1987-10-15
AT385656B AT385656B (en) 1988-05-10

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0030383A AT385656B (en) 1982-02-01 1983-01-31 METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES519450A0 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
AU2019205318B2 (en) * 2018-01-05 2022-02-03 Impel Pharmaceuticals Inc. Intranasal delivery of dihydroergotamine by precision olfactory device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (en) * 1976-11-19 1978-06-01 Sandoz Ag NEW FORMS OF ADMINISTRATION FOR ORGANIC COMPOUNDS
FR2387035A1 (en) * 1977-04-12 1978-11-10 Cassenne Lab Sa NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Also Published As

Publication number Publication date
SG34389G (en) 1989-09-22
AT385656B (en) 1988-05-10
FI830245A0 (en) 1983-01-25
LU84613A1 (en) 1983-09-08
MY8700766A (en) 1987-12-31
JPH0253406B2 (en) 1990-11-16
ES8502865A1 (en) 1985-02-01
JPS58134017A (en) 1983-08-10
NL8300325A (en) 1983-09-01
SE8300495L (en) 1983-08-02
CH653555A5 (en) 1986-01-15
NL192325B (en) 1997-02-03
DK38183D0 (en) 1983-01-31
FI81258B (en) 1990-06-29
DK164771B (en) 1992-08-17
FR2539994B1 (en) 1986-10-10
CA1197783A (en) 1985-12-10
IT8347646A0 (en) 1983-02-01
GR81320B (en) 1984-12-11
IE830187L (en) 1983-08-01
IT1197558B (en) 1988-12-06
AU565613B2 (en) 1987-09-24
DE3302949C2 (en) 1992-05-21
ZA83673B (en) 1984-09-26
KE3888A (en) 1989-09-01
FR2539994A1 (en) 1984-08-03
PH22198A (en) 1988-06-28
FI81258C (en) 1990-10-10
BE895750A (en) 1983-08-01
NZ203117A (en) 1986-12-05
FI830245L (en) 1983-08-02
DK164771C (en) 1992-12-28
DK38183A (en) 1983-08-02
AU1085083A (en) 1983-08-11
PT76166A (en) 1983-02-01
PT76166B (en) 1986-02-04
SE454402B (en) 1988-05-02
DE3302949A1 (en) 1983-08-11
IE54532B1 (en) 1989-11-08
ES519450A0 (en) 1985-02-01
NL192325C (en) 1997-06-04
HU191512B (en) 1987-02-27
IL67822A0 (en) 1983-06-15
HK59989A (en) 1989-08-04
IL67822A (en) 1988-02-29
SE8300495D0 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
AT381638B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION
AT377438B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
ATA164187A (en) METHOD FOR PRODUCING A PHARMACEUTICAL POWDER
ATA151687A (en) METHOD FOR PRODUCING A PHARMACEUTICAL CAPSULE FOR THE ORAL ADMINISTRATION OF NITROFURANTOIN (SALTS, HYDRATES, COMPLEXES)
ATA904784A (en) METHOD FOR PRODUCING A MIXTURE FROM PHYSIOLOGICALLY APPLICABLE COMPOUNDS
ATA151587A (en) METHOD FOR PRODUCING A PHARMACEUTICAL CAPSULE FOR ORAL ADMINISTRATION WITH DELAYED ACTIVE SUBSTANCE RELEASE OR. COMBINED DELAYED / RAPID RELEASE OF ACTIVE SUBSTANCE
ATA170086A (en) METHOD FOR PRODUCING A SOLID, DURABLE PHARMACEUTICAL FORM
AT371708B (en) METHOD FOR PRODUCING PHARMACEUTICAL UNIT DOSAGE FORMS
AT385199B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE
AT381025B (en) METHOD FOR PRODUCING TOPICAL PHARMACEUTICAL PREPARATIONS
AT365451B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION CONTAINING ISOSORBIDE DINITRATE
ATA156187A (en) METHOD FOR PRODUCING A SOLID ORAL PHARMACEUTICAL KETOTIFIC COMPOSITION
AT382156B (en) METHOD FOR PRODUCING NEW CYCLIC 9'-THIAPEPTIDERGOTAL CALALID
ATA254886A (en) METHOD FOR PRODUCING NEW MITOMYCIN-C ANALOGS
ATA245988A (en) METHOD FOR PRODUCING ANALGETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL PREPARATION
AT388670B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION WITH A CONTENT OF CALCIUMANTAGONISTS
DE3381345D1 (en) METHOD FOR PRODUCING A COMBINED PHARMACEUTICAL COMPOSITION IN A GRANULAR HETEROGENIC DOSE FORM WITH INCREASED BIOAVAILABILITY.
ATA221181A (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
AT385656B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, CONTAINING A CYCLIC ERGOT PEPTIDE ALKALOID
DD137670A5 (en) METHOD FOR PRODUCING A NEW PHARMACEUTICAL COMPOSITION
ATA92982A (en) METHOD FOR PRODUCING A PHARMACEUTICAL PARENTERAL DOSING UNIT OF NA-PIPERACILLIN
ATA207887A (en) METHOD FOR PRODUCING A PHARMACEUTICAL NICORANDIL PREPARATION FOR PERCUTANIC ABSORPTION
AT383272B (en) METHOD FOR PRODUCING PHARMACEUTICAL TABLETS
ATA347677A (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION
ATA206087A (en) METHOD FOR PRODUCING AN OCTREOTIDE-CONTAINING PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
ELA Expired due to lapse of time